nference Establishes AI Initiative with Takeda to Advance Precision Medicine in Inflammatory Bowel Disease

nference | New Research from nference and Mayo Clinic Suggests Monoclonal Antibody Treatments Prevent Hospitalization for COVID-19 Patients

nference today announced publication of two studies providing important evidence that treatment of high-risk, mild to moderate COVID-19 patients with monoclonal antibodies significantly reduces risk of hospitalization.

New Research from nference and Mayo Clinic Suggests Monoclonal Antibody Treatments Prevent Hospitalization for COVID-19 Patients